SIONNA THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SIONNA THERAPEUTICS, INC. (SION) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.34 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- SIONNA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 7.13M shares, a 25.41% increase year-over-year.
- SIONNA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 5.68M shares, a 81.57% decline year-over-year.
- SIONNA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 30.83M shares.
- SIONNA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 5.77M shares, a 81.35% decline from fiscal 2024.
- SIONNA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 30.93M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 7.34M shares 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 7.13M shares 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 5.77M shares 10-K · filed 2026-03-02 | |||
| 2025-09-30 | 5.71M shares 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 5.97M shares 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 5.68M shares 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | 30.93M shares 10-K · filed 2026-03-02 | |||
| 2024-09-30 | 30.92M shares 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | 30.75M shares 10-Q · filed 2025-08-11 | |||
| 2024-03-31 | 30.83M shares 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |